Levity Review

Levity in one line: branded pens only, one all-in price, no compounding

Levity is the rare GLP-1 telehealth service that sells exactly what your doctor would hand you at a brick-and-mortar pharmacy: real, FDA-approved branded pens — Mounjaro, Wegovy, and Ozempic — and nothing compounded. That single decision shapes everything else about it, including the price. If you have spent any time comparing GLP-1 providers, you already know most of the cheap options are selling compounded semaglutide or tirzepatide mixed by a pharmacy. Levity deliberately doesn't. You pay a premium for that, and whether it's worth it comes down to one question we'll keep returning to: do you specifically want the brand-name product, or just the active drug?

How the pricing actually works — one flat fee per drug, billed monthly

There are no dose tiers to decode here, which is refreshing. Levity charges one bundled monthly fee tied to the drug you're on, and that fee stays the same whether you're titrating up or holding steady. Ozempic is the entry point at $1199 a month, Mounjaro sits in the middle, and Wegovy is the most expensive of the three. A first-month discount code knocks a modest amount off your opening order, but there's no aggressive teaser rate that balloons later — the second-month price is essentially the same as the first. Billing runs roughly every four weeks, shipped on the same cadence, and you can cancel anytime.

What's folded into that one number is genuinely everything: the doctor consultation and prescription, the medication itself, shipping, and ongoing clinical care with progress tracking. You're not going to get nickel-and-dimed with a separate consult charge or a membership fee stacked on top. For comparison, the category median cash price across the providers we track is around $170 a month — so understand clearly that Levity is a multiple of that, by design, because that median is dominated by compounded products.

The medications: weekly pens, exactly as the manufacturer makes them

You get the actual branded injector pens — Eli Lilly's Mounjaro for tirzepatide, and Novo Nordisk's Wegovy or Ozempic for semaglutide — as once-weekly injections. There is no oral option and no compounded vial-and-syringe setup. The upside is obvious: consistent, manufacturer-sealed dosing with the device most people find easiest to use, and zero ambiguity about what's in the medication. The trade-off is just as obvious: branded supply is expensive and, at times over the past couple of years, hard to keep in stock industry-wide, so availability of a specific drug can move.

Who this branded-only model genuinely suits

• People who want the brand name specifically — because their clinician recommended it, because they tried compounded and didn't like the experience, or because they simply trust a sealed manufacturer pen more.
• Patients who'd rather pay one predictable bundled fee than juggle a low medication price plus surprise consult and shipping add-ons.
• Anyone who values dose simplicity: the price doesn't change as you climb the titration ladder.

Who should look elsewhere

• Cost-driven shoppers. If your goal is the lowest possible monthly outlay, compounded-GLP-1 providers undercut Levity dramatically, and even the cash-pay branded route through a manufacturer's own savings program can land lower.
• Anyone hoping to run it through insurance — a bundled cash fee like this typically can't be split or reimbursed the way a pharmacy claim can, and may cost more than a covered branded prescription with a copay.
• People who want nights-and-weekends support. Levity's clinical help runs US-based weekday business hours, not around the clock.

Trust, oversight, and what we could verify

This is where Levity earns back some of its premium. It carries a LegitScript certification — the accreditation that legitimate telehealth pharmacies display — and, unlike a lot of anonymous GLP-1 startups, it actually names the humans in charge: Dr. Phillip Whitman, PharmD, as head of pharmacy, and Dr. Abhishek Patel, MD, on the medical side. Naming real, credentialed leadership is a small thing that the sketchier corners of this market won't do. We found no FDA warning letters or enforcement actions on file against Levity. Because it dispenses only FDA-approved branded products rather than compounded formulations, it also sidesteps the regulatory gray zone that has put pressure on much of the compounding industry.

One honest caveat on confidence: Levity publishes no individual compounding-pharmacy partner detail because there's nothing to compound — the supply chain is the standard branded one. That's a plus for product certainty, but it also means your due diligence shifts to the basics: confirm the current price and your state's availability before you commit, since both can change.

Availability and the support model

Levity operates in 34 listed states, so the first thing to check is simply whether you're in one of them. Care is delivered entirely online — consultation, prescription, and refills — with progress tracking built in and unlimited messaging-style clinical support during business hours. It's a competent, no-frills support setup. Just calibrate expectations: "unlimited" here means you won't be metered on questions, not that someone is answering at midnight.

Bottom line

Levity is a focused, transparent, premium-priced service that does one thing on purpose: get you a genuine branded GLP-1 pen with the prescription, shipping, and follow-up care wrapped into a single monthly bill. The named pharmacy and physician leadership plus LegitScript certification make it more trustworthy than the average cash-pay startup, and the flat per-drug pricing is easy to understand. But you are paying brand-name prices — several times the typical compounded rate — for that peace of mind. If the brand is what you want and the cost works for your budget, Levity delivers it cleanly. If you're optimizing for price, this isn't your provider. See our scoring methodology for how we weigh price, trust, and access.

Worth pricing against MyStart Health ($299/month) and Gala ($1299/month) before you commit — both sit close to Levity on cost and formulation.